"Fibromyalgia
Global Clinical Trials Review, H2, 2016" is the latest addition
to MarketResearchReports.Biz industry research reports collection.
GlobalData's
clinical trial report, Fibromyalgia
Global Clinical Trials Review, H2, 2016" provides an overview of
Fibromyalgia clinical trials scenario. This report provides top line
data relating to the clinical trials on Fibromyalgia. Report includes
an overview of trial numbers and their average enrollment in top
countries conducted across the globe. The report offers coverage of
disease clinical trials by region, country (G7 & E7), phase,
trial status, end points status and sponsor type. Report also
provides prominent drugs for in-progress trials (based on number of
ongoing trials). GlobalData Clinical Trial Reports are generated
using GlobalDatas proprietary database - Pharma eTrack Clinical
trials database. Clinical trials are collated from 80+ different
clinical trial registries, conferences, journals, news etc across the
globe. Clinical trials database undergoes periodic update by dynamic
process.
The
report enhances the decision making capabilities and helps to create
an effective counter strategies to gain competitive advantage.
Download
Sample copy of this Report at :
http://www.marketresearchreports.biz/sample/sample/862835
Scope
- The report provides a
snapshot of the global clinical trials landscape
- Report provides top level
data related to the clinical trials by Region, Country (G7 & E7),
Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top
companies involved and enlists all trials (Trial title, Phase, and
Status) pertaining to the company
- The report provides all the
unaccomplished trials (Terminated, Suspended and Withdrawn) with
reason for unaccomplishment
- The Report provides
enrollment trends for the past five years
- Report provides latest news
for the past three months
Reasons to buy
- Assists in formulating key
business strategies with regards to investment
- Helps in identifying
prominent locations for conducting clinical trials which saves time
and cost
- Provides top level analysis
of Global Clinical Trials Market which helps in identifying key
business opportunities
- Supports understanding of
trials count and enrollment trends by country in global therapeutics
market
- Aids in interpreting the
success rates of clinical trials by providing a comparative scenario
of completed and uncompleted (terminated, suspended or withdrawn)
trials
- Facilitates clinical trial
assessment of the indication on a global, regional and country level
Follow us on LinkedIn:
https://www.linkedin.com/company/marketresearchreports-biz
Table
of Contents
Table
of Contents 2
List
of Tables 3
List
of Figures 4
Report
Guidance 5
Clinical
Trials by Region 6
Clinical
Trials and Average Enrollment by Country 7
Top
Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top
Five Countries Contributing to Clinical Trials in Europe 10
Top
Countries Contributing to Clinical Trials in North America 11
Top
Countries Contributing to Clinical Trials in Middle East and Africa
12
Top
Five Countries Contributing to Clinical Trials in Central and South
America 13
Clinical
Trials by G7 Countries: Proportion of Fibromyalgia to Central Nervous
System Clinical Trials 14
Clinical
Trials by Phase in G7 Countries 15
Clinical
Trials in G7 Countries by Trial Status 16
Clinical
Trials by E7 Countries: Proportion of Fibromyalgia to Central Nervous
System Clinical Trials 17
Clinical
Trials by Phase in E7 Countries 18
Clinical
Trials in E7 Countries by Trial Status 19
Clinical
Trials by Phase 20
In
Progress Trials by Phase 21
Clinical
Trials by Trial Status 22
Clinical
Trials by End Point Status 23
Subjects
Recruited Over a Period of Time 24
Clinical
Trials by Sponsor Type 25
Prominent
Sponsors 26
Top
Companies Participating in Fibromyalgia Therapeutics Clinical Trials
27
Prominent
Drugs 29
Latest
Clinical Trials News on Fibromyalgia 30
Sep
06, 2016: Tonix Pharmaceuticals Reports Topline Results from Phase 3
AFFIRM Study of TNX-102 SL in Fibromyalgia and Provides Corporate
Update 30
Jul
26, 2016: Tonix Pharmaceuticals Initiates Second Pivotal Phase 3
Clinical Study of TNX-102 SL in Fibromyalgia 30
Clinical
Trial Profile Snapshots 32
Appendix
187
Abbreviations
187
Definitions
187
Research
Methodology 188
Secondary
Research 188
About
GlobalData 189
Contact
Us 189
Disclaimer
189
Source
190
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment